Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

Systemic Lupus Erythematosus and Accelerated Aging

ID
Name
CHUBX 2022/53
Description
The study aims at evaluating the phenomena of immune system aging in patients with Systemic lupus erythematosus.
Trial arms
Trial start
2023-09-08
Estimated PCD
2025-09-01
Trial end
2025-09-01
Status
Recruiting
Treatment
blood sample
48 ml whole blood for Peripheral blood mononuclear cell (PBMC) and serum isolation
Arms:
Systemic Lupus Erythematosus
blood sample
blood for Peripheral blood mononuclear cell (PBMC) and serum isolation
Arms:
Controls
Size
75
Primary endpoint
Absolute numbers of naïve T lymphocytes
At baseline (Day 0)
Eligibility criteria
Inclusion Criteria: * male or female; * age between 18 and 60 years; * Lupus patient : diagnosis of systemic lupus erythematosus according to ACR or SLICC criteria; * being affiliated to health insurance; * willing to participate and to sign informed consent. Exclusion Criteria: * pregnant or breastfeeding women; * persons deprived of their liberty by a judicial or administrative decision, minors, persons of legal age who are the object of a legal protection measure or unable to express their consent
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'NON_RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'OTHER', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 75, 'type': 'ESTIMATED'}}
Updated at
2023-09-13

1 organization

2 products

1 indication

Organization
University Hospital Bordeaux
Product
Blood Sample
Indication
Systemic Lupus Erythematosus
Product
Blood sample